Compound ID | 1226
Class: Fluoroquinolone
| Agent Type: | Synthetic; Small molecule; Direct acting; Indirect acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | DNA synthesis inhibitor. Additionally shows immunosuppressive effects |
| Target Pathogen: | Active against Clostridium difficile infection |
| Institute where first reported: | Otsuka Pharmaceutical Co. Ltd. |
| Highest development stage: | Phase 2 |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/71289877 |
| Guide to Pharmacology: | OPS-2071 |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336415/ |